difference between bulk drug and api

Popular tags

Popular on the whole site

Textile

Following coagulation, flocculants may be introduced to enhance the aggregation of these flocs. Flocculants are usually long-chain organic polymers that assist in binding the particles together to form larger aggregates, making them easier to remove from the water. For instance, polyacrylamide is frequently used for this purpose, improving the clarification process significantly.


Properties of Polyacrylamide


PAM exhibits remarkable characteristics such as high water solubility, increased viscosity, and excellent film-forming capabilities. These properties make it an ideal candidate for a variety of industrial processes. The molecular structure of PAM also allows for modifications, leading to various forms that can be engineered for specific purposes. For example, anionic PAM is used for thickening and flocculating, while cationic PAM is effective in wastewater treatment due to its charge properties that attract negatively charged particles.


The Role of API Intermediates in Pharmaceutical Development


Once produced, APIs are typically combined with excipients to create a final pharmaceutical product. Excipients are inactive substances that serve as the vehicle for the API, aiding in drug formulation, stability, and delivery. The combination of API and excipients forms the final dosage form, such as tablets, capsules, or injectables.


Chillers use water to absorb heat from the process or environment and then reject that heat to the atmosphere. This operation creates ideal conditions for scale formation and corrosion, which can result from the water’s mineral content and temperature fluctuations. Without effective treatment, scale can settle on heat exchanger surfaces, diminishing heat transfer efficiency and leading to higher energy costs. Similarly, corrosion can damage metal components, eventually causing leaks and system failures.


Popular articles

Links